Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
China Feihe Limited ( (HK:6186) ) has shared an announcement.
China Feihe Limited has scheduled a board meeting for 26 March 2026 to review and approve the group’s audited financial results for the year ended 31 December 2025. The board will also consider recommending a final dividend and address other corporate matters, a step that will shape the company’s capital return to shareholders and provide investors with clarity on its latest annual performance.
The announcement also confirms the current composition of China Feihe’s board, listing its executive, non-executive and independent non-executive directors. This underscores the company’s existing governance structure ahead of the results announcement, which may be closely watched by stakeholders for indications of strategic direction and oversight.
The most recent analyst rating on (HK:6186) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on China Feihe Limited stock, see the HK:6186 Stock Forecast page.
More about China Feihe Limited
China Feihe Limited is a Hong Kong-listed company incorporated in the Cayman Islands and headquartered in Beijing, operating through a group structure. The company is engaged in the dairy and nutrition sector, best known for its infant milk formula and related products, with a primary market focus on mainland China.
Average Trading Volume: 20,823,276
Technical Sentiment Signal: Sell
Current Market Cap: HK$34.96B
See more data about 6186 stock on TipRanks’ Stock Analysis page.